Beatriz González-Astorga

507 total citations
9 papers, 26 citations indexed

About

Beatriz González-Astorga is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Beatriz González-Astorga has authored 9 papers receiving a total of 26 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Hepatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Beatriz González-Astorga's work include Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Genetic factors in colorectal cancer (3 papers). Beatriz González-Astorga is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Genetic factors in colorectal cancer (3 papers). Beatriz González-Astorga collaborates with scholars based in Spain. Beatriz González-Astorga's co-authors include Enrique Aranda, Pilar García‐Alfonso, Nuria Rodrı́guez-Salas, Ana Ruiz‐Casado, Carles Pericay, Pablo Navarro, Rafael López‐López, Encarnación González‐Flores, Paula Jiménez‐Fonseca and Andrés J. Muñoz Martín and has published in prestigious journals such as Annals of Oncology, Cancers and Pharmaceutics.

In The Last Decade

Beatriz González-Astorga

7 papers receiving 26 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beatriz González-Astorga Spain	3	16	9	6	6	3	9	26
Eric Assenat France	3	17 1.1×	12 1.3×	5 0.8×	6 1.0×	3 1.0×	3	25
Martin Karamanliev Bulgaria	3	15 0.9×	5 0.6×	5 0.8×	6 1.0×	7 2.3×	15	26
Susan Caird Australia	3	9 0.6×	6 0.7×	3 0.5×	4 0.7×	6 2.0×	9	19
Yurii Ostapenko Ukraine	2	11 0.7×	12 1.3×	2 0.3×	7 1.2×	2 0.7×	4	23
Cuncai Zhou China	2	15 0.9×	21 2.3×	12 2.0×	8 1.3×	5 1.7×	3	30
Yusuke Noguchi Japan	6	23 1.4×	3 0.3×	3 0.5×	8 1.3×	2 0.7×	12	51
Gaëlle Sickersen France	2	17 1.1×	4 0.4×	7 1.2×	3 0.5×	4 1.3×	3	20
Gaia Colletti Italy	3	16 1.0×	3 0.3×	8 1.3×	3 0.5×	4 1.3×	5	18
Matteo Papandrea Italy	2	17 1.1×	3 0.3×	13 2.2×	4 0.7×	5 1.7×	3	22
Jes Chauviere Lee United States	4	13 0.8×	3 0.3×	4 0.7×	16 2.7×	3 1.0×	8	28

Countries citing papers authored by Beatriz González-Astorga

Since Specialization

Citations

This map shows the geographic impact of Beatriz González-Astorga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz González-Astorga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz González-Astorga more than expected).

Fields of papers citing papers by Beatriz González-Astorga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz González-Astorga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz González-Astorga. The network helps show where Beatriz González-Astorga may publish in the future.

Co-authorship network of co-authors of Beatriz González-Astorga

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz González-Astorga. A scholar is included among the top collaborators of Beatriz González-Astorga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz González-Astorga. Beatriz González-Astorga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Díaz-Villamarín, Xando, María Jesús Martínez-Pérez, Emilio Fernández-Varón, et al.. (2025). Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review. Pharmaceutics. 17(5). 542–542. 1 indexed citations

González‐Flores, Encarnación, et al.. (2023). Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review. Clinical & Translational Oncology. 26(4). 851–863. 8 indexed citations

García‐Alfonso, Pilar, Andrés J. Muñoz Martín, Paula Jiménez‐Fonseca, et al.. (2021). Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study. Cancers. 13(18). 4514–4514. 10 indexed citations

Córdoba, Laura, et al.. (2020). P-345 Evaluation of a fully automated Idylla test system for microsatellite instability in a cohort of Spanish patients with colorectal carcinoma in a single institution. Annals of Oncology. 31. S202–S202. 2 indexed citations

Córdoba, Laura, et al.. (2019). Clinical significance of BRAF mutations in colorectal cancer: A retrospective study of one institution in a real-life population. Annals of Oncology. 30. iv106–iv106. 1 indexed citations

González‐Flores, Encarnación, et al.. (2017). Experience with aflibercept as a second line chemotherapy in metastatic colorectal cancer: Safety and efficacy in a real-life population. Annals of Oncology. 28. iii110–iii111. 3 indexed citations

Pericay, Carles, Nieves Martínez Lago, Ismael Macías, et al.. (2016). P-051 Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA). Annals of Oncology. 27. ii15–ii15. 1 indexed citations

González-Astorga, Beatriz, et al.. (2015). P-266 Aflibercept as a second line chemotherapy in metastatic colorectal cancer. One centre experience. Annals of Oncology. 26. iv78–iv78.

González-Astorga, Beatriz, et al.. (2013). A Retrospective Analysis of Adjuvant Chemotherapy in Elderly Patients. Experience of Our Institution. Annals of Oncology. 24. iv102–iv102.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact